what are the glp 1 drugs GLP-1 revolution: UAB researchers discovering about how these work GLP-1 Costs Explained: Managing Coverage
Description
The sustained effects of a dual GIP/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes
Frontiers in Pharmacology, 16 , Article 1539411
AAV-mediated shRNA interference of nodose ganglion in rats The left NG of male Wistar rats was surgically exposed under anesthesia (Tribromoethanol 200 mg kg 1 i.p.)
These compounds vary in chemical structure, pharmacokinetics and size, which results in different clinical effects on hyperglycaemia and body weight loss
Data Sharing Statement Data sharing is not applicable to this article as no new data were created or analysed in this study
